RGBP Stock Chart & Stats
$0.01
<$0.01(50.00%)
At close: 4:00 PM EDT
$0.01
<$0.01(50.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.12
Previous CloseN/A
Volume6.62M
Average Volume (3M)1.14M
Market Cap
$143.53K
Enterprise Value$970.96K
Total Cash (Recent Filing)$239.00
Total Debt (Recent Filing)$924.72K
Price to Earnings (P/E)―
Beta-4.21
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding1,435,277,500
10 Day Avg. Volume325,927
30 Day Avg. Volume1,142,884
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.05
Price to Sales (P/S)1.34
P/FCF Ratio-0.83
Enterprise Value/Market Cap6.76
Enterprise Value/Revenue4.10
Enterprise Value/Gross Profit4.10
Enterprise Value/Ebitda-0.86
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Regen Biopharma News
RGBP FAQ
What was Regen Biopharma’s price range in the past 12 months?
Regen Biopharma lowest stock price was <$0.01 and its highest was $0.12 in the past 12 months.
What is Regen Biopharma’s market cap?
Regen Biopharma’s market cap is $143.53K.
When is Regen Biopharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Regen Biopharma’s earnings last quarter?
Regen Biopharma released its earnings results on May 14, 2018. The company reported -$0.008 earnings per share for the quarter.
Is Regen Biopharma overvalued?
According to Wall Street analysts Regen Biopharma’s price is currently Overvalued.
Does Regen Biopharma pay dividends?
Regen Biopharma does not currently pay dividends.
What is Regen Biopharma’s EPS estimate?
Regen Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Regen Biopharma have?
Regen Biopharma has 1,435,277,500 shares outstanding.
What happened to Regen Biopharma’s price movement after its last earnings report?
Regen Biopharma reported an EPS of -$0.008 in its last earnings report. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Regen Biopharma?
Currently, no hedge funds are holding shares in RGBP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Regen Biopharma
Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.